PURPOSE: To assess the development of beta-amyloid (Abeta) plaques in the brain with age in the transgenic mouse model of Alzheimer's disease (AD) pathology by in vivo magnetic resonance microimaging (microMRI). MATERIALS AND METHODS: Live transgenic mice (Tg2576) and nontransgenic littermates (control) were studied at regular intervals between the ages of 12 and 18 months. Plaques were visualized using a T(2)-weighted rapid acquisition with relaxation enhancement (RARE) sequence. Changes in T(2) relaxation times were followed using a multislice multiecho (MSME) sequence. Plaque load and numerical density in MR images were calculated using SCIL image software. RESULTS: Abeta plaques were clearly detected with the T(2)-weighted RARE sequence in the hippocampal and cortical regions of the brain of Tg2576 mice but not in control mice. Following the plaque development in the same animals with age showed that plaque area, number, and size increased markedly, while T(2) relaxation time showed a decreasing trend with age. CONCLUSION: These results demonstrate that microMRI is a viable method for following the development of Abeta plaques in vivo, and suggest that this method may be feasible for assessing the effect of therapeutic interventions over time in the same animals.
PURPOSE: To assess the development of beta-amyloid (Abeta) plaques in the brain with age in the transgenicmouse model of Alzheimer's disease (AD) pathology by in vivo magnetic resonance microimaging (microMRI). MATERIALS AND METHODS: Live transgenic mice (Tg2576) and nontransgenic littermates (control) were studied at regular intervals between the ages of 12 and 18 months. Plaques were visualized using a T(2)-weighted rapid acquisition with relaxation enhancement (RARE) sequence. Changes in T(2) relaxation times were followed using a multislice multiecho (MSME) sequence. Plaque load and numerical density in MR images were calculated using SCIL image software. RESULTS:Abeta plaques were clearly detected with the T(2)-weighted RARE sequence in the hippocampal and cortical regions of the brain of Tg2576 mice but not in control mice. Following the plaque development in the same animals with age showed that plaque area, number, and size increased markedly, while T(2) relaxation time showed a decreasing trend with age. CONCLUSION: These results demonstrate that microMRI is a viable method for following the development of Abeta plaques in vivo, and suggest that this method may be feasible for assessing the effect of therapeutic interventions over time in the same animals.
Authors: Basavaraju G Sanganahalli; Peter Herman; Kevin L Behar; Hal Blumenfeld; Douglas L Rothman; Fahmeed Hyder Journal: Neuroimage Date: 2013-05-03 Impact factor: 6.556
Authors: Nathan O Solberg; Ryan Chamberlin; Jenette R Vigil; Lorraine M Deck; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; Marco Bisoffi; Virginia Severns; David L Vander Jagt; Laurel O Sillerud Journal: J Alzheimers Dis Date: 2014 Impact factor: 4.472
Authors: Seyedmehdi Hossaini Nasr; Hovig Kouyoumdjian; Christiane Mallett; Sherif Ramadan; David C Zhu; Erik M Shapiro; Xuefei Huang Journal: Small Date: 2017-11-14 Impact factor: 13.281
Authors: Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: Ping Yan; Adam W Bero; John R Cirrito; Qingli Xiao; Xiaoyan Hu; Yan Wang; Ernesto Gonzales; David M Holtzman; Jin-Moo Lee Journal: J Neurosci Date: 2009-08-26 Impact factor: 6.167
Authors: John A Ronald; Yuanxin Chen; Lisa Bernas; Hagen H Kitzler; Kem A Rogers; Robert A Hegele; Brian K Rutt Journal: Brain Date: 2009-03-17 Impact factor: 13.501